September 22, 2025, Part B News
Preventive Measures, Appropriate Responses Reduce Litigation Risks
You can’t eliminate the risk that a patient will sue your practice, but there are ways you can reduce the risk of lawsuits, protect your staff, and increase patient satisfaction at the same time.
Search
March 03, 2025, Part B News
Bird Flu, Measles Spread: If You’re Nearby, Take Precautionary Steps
Rich Cahill, Vice President and Associate General Counsel for The Doctors Company, part of TDC Group, shares the most up-to-date guidance on managing bird flu and measles.
August 12, 2024, Part B News
Your Patient Wants Records Sent Via Unsecure Email. Are You Covered?
Richard Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, provides recommendations for how to respond when patients request emailed medical records.
Jan 30, 2025
Off-Label Use: Patient Safety Implications
Once authorized, a drug product may be prescribed by a licensed healthcare practitioner for any use deemed appropriate based on the practitioner’s professional opinion. The governing standard is what other similarly trained practitioners would do—not what the manufacturer of the medication or product recommends.
Third Party (Credentialing Facilities) FAQs
Answers to some of the common questions that third parties ask during the credentialing process
Sep 05, 2025
Preventing Errors in Preoperative Clearance
Take this course to learn potential communication deficits in clinician-patient communication and how to incorporate an effective communication tool to reduce the risk of patient harm.
From
The Doctor’s Advocate
Insurance Applicant Business Associate Agreement
This Business Associate Agreement is entered into by and between The Doctors Company, an Interinsurance Exchange, including all of its subsidiaries.
Professional Education
Module 6: Controlled Substance Utilization Review and Evaluation System (CURES) (Innovations and Smart Approaches in Safe Prescribing)
This program reviews the CURES electronic database for Schedule II, III, IV, V controlled substance prescriptions dispensed in California, including time requirements involved when dispensing information needs to be reported (a controlled substance is released to the patient or patient's representative). This module will examine how non-DEA licensed physicians and surgeon practitioners can access CURES data. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Effective Patient-Assisted Telehealth Assessments
Physicians who practice telemedicine must consider the components needed to complete an effective remote assessment and plan ahead based on their specialty area and the patient’s presenting complaint.
Mar 04, 2024
Patient Safety Impact Story: Documentation Can Prevent Litigation
Our experts partnered with a general surgery practice to dramatically improve its after-hours call documentation rate.
From
The Doctor’s Advocate
